0001144204-17-001916.txt : 20170503 0001144204-17-001916.hdr.sgml : 20170503 20170112094323 ACCESSION NUMBER: 0001144204-17-001916 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20170112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 CORRESP 1 filename1.htm

 

 

90 Park Avenue

New York, NY 10016

 

212-210-9400

Fax: 212-210-9444

www.alston.com

 

Mark F. McElreath Direct Dial: 212-210-9595 Email: mark.mcelreath@alston.com

 

January 12, 2017

 

Ms. Suzanne Hayes

Assistant Director

Office of Health Care and Insurance

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Mail Stop 3561

Washington, D.C. 20549

 

Re:

Avenue Therapeutics, Inc.

Comparison of the Form 10-12G filed on January 12, 2017 against the Form 10-12G/A filed on February 18, 2016.

File No. 000-55556

 

Dear Ms. Hayes:

 

At the request and on behalf of our client, Avenue Therapeutics, Inc., a Delaware corporation (the “Company”), please find enclosed with this letter a courtesy copy of the Company’s current General Form for Registering Securities on Form 10-12G, filed on January 12, 2017 (the “Form 10-12G”) marked against the Company’s Amended General Form for Registering Securities on Form 10-12G/A, filed on February 18, 2016 (the “Form 10-12G/A”).

 

If you have any questions, comments or informational requests relating to this matter, please do not hesitate to contact me at the telephone number above.

 

  Sincerely,
   
   
  Mark F. McElreath

 

 

 

 

 

 

 

 

 

 

 

Atlanta • Beijing • Brussels • Charlotte • Dallas • Los Angeles • New York • Research Triangle • Silicon Valley • Ventura County • Washington, D.C.

 

 

 

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end